Zhejiang Medicine: Has repurchased 440,700 shares with a total amount of funds used of 5.8959 million yuan

Zhejiang Medicine announced that on April 14, 2025, the board of directors approved a share repurchase plan, intending to repurchase shares with funds ranging from 100 million to 200 million yuan through centralized bidding, for the purpose of an employee stock ownership plan or equity incentive. As of May 12, 2025, the company had repurchased a total of 440,700 shares, accounting for 0.05% of the company's total share capital, with a repurchase price range of 13.31 yuan/share to 13.43 yuan/share, and a total expenditure of 5.8959 million yuan. This repurchase complies with relevant laws and regulations and the company's established plan. The company will continue to implement the repurchase based on market conditions and disclose relevant progress in a timely manner